Attached files
| file | filename |
|---|---|
| EX-32.3 - EXHIBIT 32.3 - PLURISTEM THERAPEUTICS INC | exhibit_32-3.htm |
| EX-32.2 - EXHIBIT 32.2 - PLURISTEM THERAPEUTICS INC | exhibit_32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - PLURISTEM THERAPEUTICS INC | exhibit_32-1.htm |
| EX-31.3 - EXHIBIT 31.3 - PLURISTEM THERAPEUTICS INC | exhibit_31-3.htm |
| EX-31.2 - EXHIBIT 31.2 - PLURISTEM THERAPEUTICS INC | exhibit_31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - PLURISTEM THERAPEUTICS INC | exhibit_31-1.htm |
| EX-10.41 - EXHIBIT 10.41 - PLURISTEM THERAPEUTICS INC | exhibit_10-41.htm |
| EX-10.40 - EXHIBIT 10.40 - PLURISTEM THERAPEUTICS INC | exhibit_10-40.htm |
| 10-K - 10-K - PLURISTEM THERAPEUTICS INC | zk1720512.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-3 (Registration No. 333-218916) and in the related prospectus and in the Registration Statements on Form S-8 (Registration No. 333-217770, 333-212299, 333-206848, 333-196537, 333-173777 and 333-162577) of Pluristem Therapeutics Inc. of our reports dated September 7, 2017, with respect to the consolidated financial statements of Pluristem Therapeutics Inc., and the effectiveness of internal control over financial reporting of Pluristem Therapeutics Inc., included in this Annual Report (Form 10-K) for the year ended June 30, 2017.
|
/s/ Kost Forer Gabbay & Kasierer
|
||
|
Haifa, Israel
|
Kost Forer Gabbay & Kasierer
|
|
|
September 7, 2017
|
A Member of Ernst & Young Global
|